BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37070439)

  • 21. Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia.
    So J; Lewis AC; Smith LK; Stanley K; Franich R; Yoannidis D; Pijpers L; Dominguez P; Hogg SJ; Vervoort SJ; Brown FC; Johnstone RW; McDonald G; Ulanet DB; Murtie J; Gruber E; Kats LM
    EMBO Mol Med; 2022 Jul; 14(7):e15203. PubMed ID: 35514210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Novel
    Sibille G; Luganini A; Sainas S; Boschi D; Lolli ML; Gribaudo G
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SAR studies toward discovery of emvododstat (PTC299), a potent dihydroorotate dehydrogenase (DHODH) inhibitor.
    Baiazitov RY; Qi H; Arasu T; Lennox W; Cao L; Weetall M; Furia B; Zhuo J; Choi S; Kim MJ; Sheedy J; Davis T; Moon YC
    Eur J Med Chem; 2022 Dec; 244():114826. PubMed ID: 36242990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a human dihydroorotate dehydrogenase (hDHODH) pharma-similarity index approach with scaffold-hopping strategy for the design of novel potential inhibitors.
    Shih KC; Lee CC; Tsai CN; Lin YS; Tang CY
    PLoS One; 2014; 9(2):e87960. PubMed ID: 24504131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a biomarker to monitor target engagement after treatment with dihydroorotate dehydrogenase inhibitors.
    Pontikos MA; Leija C; Zhao Z; Wang X; Kilgore J; Tornesi B; Adenmatten N; Phillips MA; Williams NS
    Biochem Pharmacol; 2022 Oct; 204():115237. PubMed ID: 36055381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach.
    Khairy A; Hammoda HM; Celik I; Zaatout HH; Ibrahim RS
    Sci Rep; 2022 Nov; 12(1):19037. PubMed ID: 36351991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells.
    Mohamad Fairus AK; Choudhary B; Hosahalli S; Kavitha N; Shatrah O
    Biochimie; 2017 Apr; 135():154-163. PubMed ID: 28196676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agent.
    Alberti M; Poli G; Broggini L; Sainas S; Rizzi M; Boschi D; Ferraris DM; Martino E; Ricagno S; Tuccinardi T; Lolli ML; Miggiano R
    Acta Crystallogr D Struct Biol; 2024 Jun; 80(Pt 6):386-396. PubMed ID: 38805244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer.
    Mullen NJ; Thakur R; Shukla SK; Chaika NV; Kollala SS; Wang D; He C; Fujii Y; Sharma S; Mulder SE; Sykes DB; Singh PK
    Cancer Lett; 2023 Jan; 552():215981. PubMed ID: 36341997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment.
    Li C; Yang X; Luo Y; Liu H; Zhong X; Zhou X; Zeng T; Tao L; Zhou Y; Gou K; Yang X; Liu X; Chen Q; Zhao Y; Luo Y
    J Med Chem; 2021 Dec; 64(24):18175-18192. PubMed ID: 34905371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase.
    Zeng F; Quan L; Yang G; Qi T; Zhang L; Li S; Li H; Zhu L; Xu X
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31370178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia.
    Sexauer AN; Alexe G; Gustafsson K; Zanetakos E; Milosevic J; Ayres M; Gandhi V; Pikman Y; Stegmaier K; Sykes DB
    Blood Adv; 2023 Nov; 7(21):6685-6701. PubMed ID: 37648673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiratricol, a thyroid hormone metabolite, has potent inhibitory activity against human dihydroorotate dehydrogenase.
    Cao S; Ma H; Xu Z; Fang W; Huang J; Huang Y
    Chem Biol Drug Des; 2023 Jul; 102(1):1-13. PubMed ID: 37088711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel series of human dihydroorotate dehydrogenase inhibitors discovered by in vitro screening: inhibition activity and crystallographic binding mode.
    Zeng T; Zuo Z; Luo Y; Zhao Y; Yu Y; Chen Q
    FEBS Open Bio; 2019 Aug; 9(8):1348-1354. PubMed ID: 31087527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent human dihydroorotate dehydrogenase inhibitory activity of new quinoline-4-carboxylic acids derived from phenolic aldehydes: Synthesis, cytotoxicity, lipophilicity and molecular docking studies.
    Petrović MM; Roschger C; Chaudary S; Zierer A; Mladenović M; Jakovljević K; Marković V; Botta B; Joksović MD
    Bioorg Chem; 2020 Dec; 105():104373. PubMed ID: 33074120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive drug repurposing study for COVID19 treatment: novel putative dihydroorotate dehydrogenase inhibitors show association to serotonin-dopamine receptors.
    Berber B; Doluca O
    Brief Bioinform; 2021 Mar; 22(2):1023-1037. PubMed ID: 33406218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.
    Kim YJ; Cubitt B; Cai Y; Kuhn JH; Vitt D; Kohlhof H; de la Torre JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.
    Boukalova S; Hubackova S; Milosevic M; Ezrova Z; Neuzil J; Rohlena J
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165759. PubMed ID: 32151633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DHODH and cancer: promising prospects to be explored.
    Zhou Y; Tao L; Zhou X; Zuo Z; Gong J; Liu X; Zhou Y; Liu C; Sang N; Liu H; Zou J; Gou K; Yang X; Zhao Y
    Cancer Metab; 2021 May; 9(1):22. PubMed ID: 33971967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.